Home › FTC Settles Charges That Actavis's Proposed $8.5 Billion Acquisition...
 

Keywords :   


FTC Settles Charges That Actavis's Proposed $8.5 Billion Acquisition...

2013-09-28 10:29:05| Biotech - Topix.net

International drug manufacturer Actavis, Inc. has agreed to sell all rights and assets to four generic pharmaceuticals - three oral contraceptives and an osteoporosis treatment - to settle FTC charges that its proposed $8.5 billion acquisition of drug-maker Warner Chilcott plc would be anticompetitive.

Tags: proposed charges billion acquisition

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
02.07Greyparrot and VAN DYK Bring AI to MRFs Across the U.S.
02.07Grove Collaborative Announces New Sustainability Goals, Recommits to Moving the Industry Beyond Plastic
02.07Aldi Chops Off Pineapple Crowns in a New Trial to Save 1,400 Tonnes of Food Waste
02.07Virginia Waste-to-Energy Plant Closes, Waste Now Heading for Landfill That is Running Out of Space
02.07Hurricane Beryl Graphics
02.07Eastern North Pacific Tropical Weather Outlook
02.07Hurricane Beryl Public Advisory Number 15A
02.07Summary for Hurricane Beryl (AT2/AL022024)
More »